Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response
- 24 February 2015
- journal article
- research article
- Published by Elsevier BV in Biomaterials
- Vol. 52, 126-139
- https://doi.org/10.1016/j.biomaterials.2015.02.004
Abstract
No abstract availableKeywords
Funding Information
- Science Foundation of China (51133004, 81371666, 81361140343)
- National Basic Research Program of China (2011CB606206)
- Excellent Scholars Fund of Sichuan University (2013SCU04A09)
This publication has 61 references indexed in Scilit:
- Mitochondrial Fission, Fusion, and StressScience, 2012
- Genetic heterogeneity and cancer drug resistanceThe Lancet Oncology, 2012
- Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivoJournal of Controlled Release, 2012
- Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastomaProceedings of the National Academy of Sciences of the United States of America, 2011
- The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticlesBiomaterials, 2011
- Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdvanced Drug Delivery Reviews, 2009
- The effect of particle design on cellular internalization pathwaysProceedings of the National Academy of Sciences of the United States of America, 2008
- Drug Delivery with Carbon Nanotubes for In vivo Cancer TreatmentCancer Research, 2008
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002